Almirall S.A.

Almirall is a skin-health focused global pharmaceutical founded over 75 years ago. It has its headquarters in Barcelona (Spain) and its main R&D center in located in Spain. Total Revenues in 2020 were more than 800 million euros. Almirall has  c. 1,800 employees, 15% of them devoted to R&D activities. R&D capabilities cover the whole value chain, from the idea to registration. Our efforts are focus to medical dermatological conditions, ranging from large indications, such as psoriasis and atopic dermatitis, to more niche indications, where treatments are scarce or even absent. We use the most appropriate therapeutic approach, such as new chemical entities, biologics or other innovative platforms, to address the challenges posed by each specific disease.